An Economic Modeling Study of Helicobacter pylori Eradication: Comparison of Dual Priming Oligonucleotide-Based Multiplex Polymerase Chain Reaction and Empirical Treatment

키워드

참고문헌 (29)

1. Lee JW, "Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012", Helicobacter, 18, pp.206~214 (2013)
2. Megraud F, "Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption", Gut, 62, pp.34~42 (2013)
3. Sasaki H, "Ten-year trend of the cumulative Helicobacter pylori eradication rate for the ‘Japanese eradication strategy’", Digestion, 88, pp.272~278 (2013)
4. Shin WG, "Eradication rates of Helicobacter pylori in Korea over the past 10 years and correlation of the amount of antibiotics use: nationwide survey", Helicobacter, 21, pp.266~278 (2016)
5. Chey WD, "ACG clinical guideline: treatment of Helicobacter pylori onfection", Am J Gastroenterol, 112, pp.212~239 (2017)
6. Horiki N, "Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan", Helicobacter, 14, pp.86~90 (2009)
7. Hwang TJ, "Change in antibiotic resistance of Helicobacter pylori strains and the effect of A2143G point mutation of 23S rRNA on the eradication of H. pylori in a single center of Korea", J Clin Gastroenterol, 44, pp.536~543 (2010)
8. Graham DY, "How to effectively use bismuth quadruple therapy: the good, the bad, and the ugly", Gastroenterol Clin North Am, 44, pp.537~563 (2015)
9. Liou JM, "Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial", Lancet, 388, pp.2355~2365 (2016)
10. Liou JM, "Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of Helicobacter pylori: a randomized trial", Am J Gastroenterol, 111, pp.381~387 (2016)
11. Chen Q, "Rescue therapy for Helicobacter pylori eradication: a randomized non-inferiority trial of amoxicillin or tetracycline in bismuth quadruple therapy", Am J Gastroenterol, 111, pp.1736~1742 (2016)
12. Suzuki S, "The efficacy and tolerability of a triple therapy containing a potassiumcompetitive acid blocker compared with a 7-day PPI-based lowdose clarithromycin triple therapy", Am J Gastroenterol, 111, pp.949~956 (2016)
13. Park CS, "Pretreatment antimicrobial susceptibility- guided vs. clarithromycin-based triple therapy for Helicobacter pylori eradication in a region with high rates of multiple drug resistance", Am J Gastroenterol, 109, pp.1595~1602 (2014)
14. Cosme A, "Antimicrobial susceptibility- guided therapy versus empirical concomitant therapy for eradication of Helicobacter pylori in a region with high rate of clarithromycin resistance", Helicobacter, 21, pp.29~34 (2016)
15. Toracchio S, "Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication", Aliment Pharmacol Ther, 14, pp.1639~1643 (2000)
16. Romano M, "Pretreatment antimicrobial-susceptibility testing in the eradication of H. pylori infection", Am J Gastroenterol, 95, pp.3317~3318 (2000)
17. Bae SE, "Effect of Helicobacter pylori eradication on metachronous recurrence after endoscopic resection of gastric neoplasm", Am J Gastroenterol, 109, pp.60~67 (2014)
18. Woo HY, "Dual-priming oligonucleotidebased multiplex PCR for the detection of Helicobacter pylori and determination of clarithromycin resistance with gastric biopsy specimens", Helicobacter, 14, pp.22~28 (2009)
19. Lehours P, "DPO multiplex PCR as an alternative to culture and susceptibility testing to detect Helicobacter pylori and its resistance to clarithromycin", BMC Gastroenterol, 11, pp.112~ (2011)
20. Lee HJ, "Eradication of Helicobacter pylori according to 23S ribosomal RNA point mutations associated with clarithromycin resistance", J Infect Dis, 208, pp.1123~1130 (2013)
21. Bahin FF, "Prophylactic clipping for the prevention of bleeding following wide-field endoscopic mucosal resection of laterally spreading colorectal lesions: an economic modeling study", Endoscopy, 48, pp.754~761 (2016)
22. Hu Y, "Primary antibiotic resistance of Helicobacter pylori in China", Dig Dis Sci, 62 (2017)
23. Liu Q, "Efficacy of real-time PCR-based detection of Helicobacter pylori infection and genotypic resistanceguided quadruple therapy as the first-line treatment for functional dyspepsia with Helicobacter pylori infection", Eur J Gastroenterol Hepatol, 27, pp.221~225 (2015)
24. 장현주, "Helicobacter pylori 감염 1차 치료를 위한 삼제요법과 사제요법의 제균 효과", 대한소화기학회지, 46(5), pp.368~372 (2005), 대한소화기학회
25. Jung YS, "Efficacy of Helicobacter pylori eradication therapies in Korea: a systematic review and network meta-analysis", Helicobacter, 22, pp.e12389~ (2017)
26. Yuan Y, "Optimum duration of regimens for Helicobacter pylori eradication", Cochrane Database Syst Rev, (12), pp.CD008337~ (2013)
27. Calvet X, "A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection", Aliment Pharmacol Ther, 14, pp.603~609 (2000)
28. Kim BG, "Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea", Helicobacter, 12, pp.31~35 (2007)
29. Filipec Kanizaj T, "Helicobacter pylori eradication therapy success regarding different treatment period based on clarithromycin or metronidazole tripletherapy regimens", Helicobacter, 14, pp.29~35 (2009)

관련 논문AI추천